Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.00
Clene Inc., a clinical-stage biopharmaceutical company, focuses on the development of various therapies for neurodegenerative diseases. The company is headquartered in Salt Lake City, Utah.
See the full interactive analysis & chart →Informational only — not investment advice.